The depletion of uridine in the tumor microenvironment leads to the impairment of CD8+ T cell function. (PRJCA049679)
Analysis of samples from patients treated with immune checkpoint inhibitors led to the identification of SNX17 as a gene conferring resistance. Subsequent mass spectrometry analysis revealed that the tumor-derived SNX17 gene modulates CD8+ T cells through the metabolite uridine.